Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab in Glaucoma Tube Surgery
NCT00644280Phase 2Terminated
- Sponsor
- University of California, San Francisco
- Start
- Apr 2008
- Primary completion
- Dec 2010
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in Glaucoma, sponsored by University of California, San Francisco. Started Apr 2008; status: terminated.
02
Drugs
ranibizumab
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT00644280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644280.